Verition Fund Management LLC Medicenna Therapeutics Corp. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.51 $9,550 - $17,395	-34,108 Reduced 5.79%	555,392 $166,000
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.82 $6,119 - $11,403	-13,907 Reduced 2.3%	589,500 $282,000
Q1 2023 May 15, 2023	BUY	$0.5 - $0.78 $32,178 - $50,197	64,356 Added 11.94%	603,407 $380,000
Q1 2021 May 18, 2021	SELL	$3.5 - $4.56 $2,100 - $2,735	-600 Reduced 0.11%	539,051 $2.2 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $5.97 $2 Million - $3.22 Million	539,651 New	539,651 $2.53 Million

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.